“ At Biomed, we prioritize delivering value to patients and operating ethically, rather than focusing solely on maximizing profits ”
In Conversation
“ Despite recent advances in cancer immunotherapy, approximately 80 percent of patients still do not respond, or become resistant, to currently available immuno-oncology treatments ”
“ Respecting our legacy as a Japanese company while adapting to the cultural context of Mexico drives our success ”
“ We are committed to taking calculated risks and fostering an entrepreneurial spirit that propels our organization forward ”
“ We want to partner with biotechs around ‘the making of the molecule,’ whether small molecules or biologics ”
“ Integrity is always doing the right thing for patients, employees, communities, and our stakeholders. It is trusting in what we do, how we do it, and… ”
“ The Swiss healthcare law (KVG) outlines three key pillars: benefit, quality and security of supply, and cost affordability. All three are supposed to be considered equally,… ”
“ We need to expand the number of therapies that are regularly reimbursed and reduce the reliance on individual approvals. This is a challenge we are actively… ”
“ Apart from its strategic location, Mexico is a large market with many competitive advantages ”
“ In the past, companies used to conduct separate clinical trials in the US, Europe, and then in China. Now, with simultaneous approvals, Chinese patients can access… ”
“ Switzerland’s appeal as a destination for talent is bolstered by factors beyond the industry’s control, like over a century of political stability, a robust legal framework,… ”
“ Mexico has all the ingredients necessary to become a global hub for clinical trials—a large population of over 130 million, strong infrastructure, and a highly capable… ”